RZ-001

N/A

Report date: 2026/05/18 10:24:53

Base Information

Drug NameRZ-001

Drug Alias NameRZ-001

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > RibozymeCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector

Mechanisms of ActionTelomerase reverse transcriptase modulators

TargetsTelomerase reverse transcriptase

Therapy Area/IndicationsCarcinoma, HepatocellularGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesRznomics Inc

China Registration ClassN/A

Develop Information

Active CompaniesRznomics Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, HepatocellularGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A